🔎 Trials Near Me

Beranda › Tumor Otak › North Carolina › Durham

Uji klinis Tumor Otak di Durham, NC

14 studi untuk Tumor Otak mencari peserta di lokasi sekitar Durham (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Menerima pesertaFase 1/2
  • Duke University School of Medicine, Durham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT05786924

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Menerima pesertaFase 2
  • Local Institution - 0100, Durham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07492680

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Menerima pesertaFase 1
  • Duke Cancer Institute, Durham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06253871

Targeted Pediatric High-Grade Glioma Therapy

Menerima pesertaStudi observasional
  • Duke University Health System, Durham
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT05839379

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

Menerima pesertaFase 2
  • Duke University, Durham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07428616

Study of Olutasidenib and Temozolomide in HGG

Menerima pesertaFase 2
  • Duke University Health System, Durham
Usia 12 hingga 39 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06161974

ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas

Menerima pesertaFase 1
  • Duke University Medical Center, Durham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05609994

MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets

Menerima pesertaStudi observasional
  • University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill · 10 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT04073966

B6 Administration for Levetiracetam-Associated Neurobehavioral Changes and Epilepsy

Menerima peserta
  • Duke University Medical Center, Durham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT07271966

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Menerima pesertaFase 2
  • Duke University Health System, Durham
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 29 Mei 2026 · NCT05843253

Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc

Menerima pesertaFase 1
  • Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Apr 2026 · NCT05366179

Key Longitudinal Associations With Risk and Glioblastoma Outcomes

Menerima pesertaStudi observasional
  • Duke University, Durham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Jan 2026 · NCT06625684

Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors

Menerima pesertaStudi observasional
  • Duke Cancer Center, Durham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Nov 2025 · NCT05480644

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Menerima pesertaFase 2
  • University of North Carolina, Chapel Hill · 10 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Jun 2025 · NCT03175224

Uji klinis Tumor Otak di kota lain

Studi lain di Durham

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.